The Investor's Podcast 对 $NVO 的判断变化

The Investor's Podcast 自 2026-10-31 起在 1 个视频里谈过 $NVO,最近一次(2026-10-31)为看涨。

2026-10-31看涨
《S&P Global (SPGI), Novo Nordisk (NVO), Deckers (DECK) | Stock Analysis & Valuation (TIP857)》
AI 摘要 · 看多 NVO:其前瞻市盈率约 12 倍——仅为标普 20 多倍市盈率的一半,而礼来为 24 倍——大部分坏消息已被计入。基准情形为中个位数盈利增长加上 4.5% 股息率,五年内年化回报 8–9%(含股息最高 10%);若口服减肥药和处于三期的 amiritin 在 2028 年前成功,重估后回报可达 18–22%。他不指望明年翻倍,并提到 Medicare 定价、专利到期/仿制药、指引下调至 2030 年以及价值陷阱/创新风险。

所以我今天的选择是两年前欧洲市值最高的公司之一。几乎人人都持有它。我不知道你Stig是否持有,但很多人、很多ETF、很多基金都持有这家公司。

So my pick today is one of those companies which two years ago was the most valuable company in Europe. And pretty much everybody owned it. I don't know whether you owned it Stig, but pretty much a lot of people, a lot of ETFs, a lot of funds owned this company.

分析师非常喜欢它。但今天这只股票下跌了40%。从52周高点算起,而且它的交易价格大约是远期盈利的12倍,基本上所有人都在说派对结束了。

The analysts really loved it. But today that stock is down 40%. And from its 52- week high and it's trading roughly around 12 times forward earnings and basically everybody's saying parties over here.